Geoffrey Ling MD - 12 Jan 2026 Form 4/A - Amendment Insider Report for Celularity Inc (CELU)

Role
Director
Signature
/s/ Geoffrey Ling, MD
Issuer symbol
CELU
Transactions as of
12 Jan 2026
Net transactions value
$0
Form type
4/A - Amendment
Filing time
15 Jan 2026, 16:15:29 UTC
Date Of Original Report
14 Jan 2026
Previous filing
30 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ling Geoffrey M.D. Director C/O CELULARITY INC., 170 PARK AVENUE, FLORHAM PARK /s/ Geoffrey Ling, MD 15 Jan 2026 0001800097

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Award $0 +19,231 +8.1% $0.000000 256,026 12 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.